Literature DB >> 28806157

Human Vaccines & Immunotherapeutics: News.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28806157      PMCID： PMC5557241          DOI： 10.1080/21645515.2017.1356176

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


× No keyword cloud information.
  3 in total

1.  Trends in Nationwide Herpes Zoster Emergency Department Utilization From 2006 to 2013.

Authors:  Erica D Dommasch; Cara J Joyce; Arash Mostaghimi
Journal:  JAMA Dermatol       Date:  2017-09-01       Impact factor: 10.282

2.  Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study.

Authors:  D Gray Heppner; Tracy L Kemp; Brian K Martin; William J Ramsey; Richard Nichols; Emily J Dasen; Charles J Link; Rituparna Das; Zhi Jin Xu; Eric A Sheldon; Teresa A Nowak; Thomas P Monath
Journal:  Lancet Infect Dis       Date:  2017-06-09       Impact factor: 25.071

3.  The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP mice.

Authors:  Christine Landlinger; Marianne G Pouwer; Claudia Juno; José W A van der Hoorn; Elsbet J Pieterman; J Wouter Jukema; Guenther Staffler; Hans M G Princen; Gergana Galabova
Journal:  Eur Heart J       Date:  2017-08-21       Impact factor: 29.983
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.